RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Shandong Weigao Group Medical Polymer Co Stock

Shandong Weigao Group Medical Polymer Co Equity 2024

Shandong Weigao Group Medical Polymer Co Equity

22.45 B CNY

Ticker

1066.HK

ISIN

CNE100000171

WKN

A0M4WA

In 2024, Shandong Weigao Group Medical Polymer Co's equity was 22.45 B CNY, a 3.13% increase from the 21.77 B CNY equity in the previous year.

Shandong Weigao Group Medical Polymer Co Aktienanalyse

What does Shandong Weigao Group Medical Polymer Co do?

Shandong Weigao Group Medical Polymer Co Ltd is a globally operating company with headquarters in Weihai, China. It was founded in 1988 and has been listed on the Hong Kong Stock Exchange since 2004. The company specializes in the production of medical polymer products and offers a wide range of products for various applications. Its business model is that of an integrated platform for research, development, manufacturing, and marketing of medical devices. Their customers include hospitals, medical practices, and distributors worldwide. The company's portfolio includes products in the areas of infusion, blood transfusion, dialysis, surgery, anesthesia, first aid, and diagnostics. Both disposable and reusable products are available. With its offering, the company aims to contribute to improving the quality of healthcare and providing better outcomes for patients. Shandong Weigao Group Medical Polymer Co Ltd is divided into three divisions: Medical Devices, Medical Consumables, and Biology. The Medical Devices division manufactures devices for use in anesthesia, surgery, resuscitation, and diagnostics. The Medical Consumables division includes products such as syringes, catheters, infusion and transfusion devices, disposable gloves, and wound dressings. The Biology division specializes in the development, manufacturing, and marketing of biopharmaceutical products, such as insulin. The company's history is characterized by rapid expansion and continuous growth. The focus on R&D has played an important role in this. Through the use of advanced technologies, the company has acquired a multitude of patents in both China and other countries. The company places a strong emphasis on quality assurance and has implemented a comprehensive quality control system. In addition, it aims to minimize its environmental impact and therefore operates according to the latest environmental standards. In recent years, the company has established an international presence and opened subsidiaries in Europe and the USA. This demonstrates the company's desire to grow internationally and offer its products in more and more countries. In summary, Shandong Weigao Group Medical Polymer Co Ltd is an innovative company specializing in the production of medical polymer products and biopharmaceutical products. It offers a wide range of products and is committed to a comprehensive quality control system and sustainability. With its international presence, the company aims to continue growing and offer its products worldwide. Shandong Weigao Group Medical Polymer Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Shandong Weigao Group Medical Polymer Co's Equity

Shandong Weigao Group Medical Polymer Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Shandong Weigao Group Medical Polymer Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Shandong Weigao Group Medical Polymer Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Shandong Weigao Group Medical Polymer Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Shandong Weigao Group Medical Polymer Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Shandong Weigao Group Medical Polymer Co stock

What is the equity of Shandong Weigao Group Medical Polymer Co this year?

Shandong Weigao Group Medical Polymer Co has equity of 22.45 B CNY this year.

What was the equity of Shandong Weigao Group Medical Polymer Co compared to the previous year?

The equity of Shandong Weigao Group Medical Polymer Co has increased/decreased by 3.13% increased compared to the previous year.

What impact does a high equity have on investors of Shandong Weigao Group Medical Polymer Co?

A high equity is advantageous for investors of Shandong Weigao Group Medical Polymer Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Shandong Weigao Group Medical Polymer Co?

A low equity can be a risk for investors of Shandong Weigao Group Medical Polymer Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Shandong Weigao Group Medical Polymer Co affect the company?

An increase in equity of Shandong Weigao Group Medical Polymer Co can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Shandong Weigao Group Medical Polymer Co affect the company?

A reduction in equity of Shandong Weigao Group Medical Polymer Co can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Shandong Weigao Group Medical Polymer Co?

Some factors that can affect the equity of Shandong Weigao Group Medical Polymer Co include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Shandong Weigao Group Medical Polymer Co so important for investors?

The equity of Shandong Weigao Group Medical Polymer Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Shandong Weigao Group Medical Polymer Co take to change the equity?

To change equity, Shandong Weigao Group Medical Polymer Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Shandong Weigao Group Medical Polymer Co pay?

Over the past 12 months, Shandong Weigao Group Medical Polymer Co paid a dividend of 0.25 CNY . This corresponds to a dividend yield of about 6.24 %. For the coming 12 months, Shandong Weigao Group Medical Polymer Co is expected to pay a dividend of 0.27 CNY.

What is the dividend yield of Shandong Weigao Group Medical Polymer Co?

The current dividend yield of Shandong Weigao Group Medical Polymer Co is 6.24 %.

When does Shandong Weigao Group Medical Polymer Co pay dividends?

Shandong Weigao Group Medical Polymer Co pays a quarterly dividend. This is distributed in the months of November, July, July, November.

How secure is the dividend of Shandong Weigao Group Medical Polymer Co?

Shandong Weigao Group Medical Polymer Co paid dividends every year for the past 23 years.

What is the dividend of Shandong Weigao Group Medical Polymer Co?

For the upcoming 12 months, dividends amounting to 0.27 CNY are expected. This corresponds to a dividend yield of 6.79 %.

In which sector is Shandong Weigao Group Medical Polymer Co located?

Shandong Weigao Group Medical Polymer Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Shandong Weigao Group Medical Polymer Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Shandong Weigao Group Medical Polymer Co from 11/22/2024 amounting to 0.092 CNY, you needed to have the stock in your portfolio before the ex-date on 10/18/2024.

When did Shandong Weigao Group Medical Polymer Co pay the last dividend?

The last dividend was paid out on 11/22/2024.

What was the dividend of Shandong Weigao Group Medical Polymer Co in the year 2023?

In the year 2023, Shandong Weigao Group Medical Polymer Co distributed 0.172 CNY as dividends.

In which currency does Shandong Weigao Group Medical Polymer Co pay out the dividend?

The dividends of Shandong Weigao Group Medical Polymer Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Shandong Weigao Group Medical Polymer Co

Our stock analysis for Shandong Weigao Group Medical Polymer Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shandong Weigao Group Medical Polymer Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.